Eplerenone Post-AMI Heart Failure Efficacy and Survival Study - EPHESUS

Description:

The goal of the Eplerenone Post-AMI Heart Failure Efficacy and Survival Study (EPHESUS) was to determine the efficacy of the new selective aldosterone receptor blockade eplerenone in patients with acute myocardial infarction (AMI) complicated by heart failure and systolic left ventricular (LV) dysfunction.